U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Somatropin Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Eli Lilly and Co. (New 10/29/2024)

Company Contact Information:
800-545-5979

Presentation Posting Date Related Information
Humatrope, Injection, Humatrope Kit 6 mg (0002-8147-01): 1 TRAY in 1 CARTON (0002-8147-01) / 1 KIT in 1 TRAY * 2.88 mL in 1 CARTRIDGE (0002-7554-01) * 2.88 mL in 1 SYRINGE (0002-7618-01) (NDC 0002-8147-01) 10/29/2024 Business decision to discontinue. Discontinuation includes the associated HumatroPen injection device.
Humatrope, Injection, Humatrope Kit 12 mg (0002-8148-01): 1 TRAY in 1 CARTON (0002-8148-01) / 1 KIT in 1 TRAY * 2.88 mL in 1 CARTRIDGE (0002-7555-01) * 2.88 mL in 1 SYRINGE (0002-7619-01) (NDC 0002-8148-01) 10/29/2024 Business decision to discontinue. Discontinuation includes the associated HumatroPen injection device.
Humatrope, Injection, Humatrope Kit 24 mg (0002-8149-01): 1 TRAY in 1 CARTON (0002-8149-01) / 1 KIT in 1 TRAY * 2.88 mL in 1 CARTRIDGE (0002-7556-01) * 2.88 mL in 1 SYRINGE (0002-7619-01) (NDC 0002-8149-01) 10/29/2024 Business decision to discontinue. Discontinuation includes the associated HumatroPen injection device.

Genentech, Inc (New 03/22/2024)

Company Contact Information:
800-551-2231

Presentation Posting Date Related Information
Nutropin AQ, Injection, 10 mg/2 mL (NDC 50242-074-01) 03/22/2024 The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.
Nutropin AQ, Injection, 5 mg/2 mL (NDC 50242-075-01) 03/22/2024 The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.
Nutropin AQ, Injection, 20 mg/2 mL (NDC 50242-076-01) 03/22/2024 The decision to discontinue commercial distribution of Nutropin AQ in the United States is a business decision, taken in view of the availability of generic and alternative treatments for patients, and is not related to any quality, safety or efficacy concerns with the product.
Back to Top